HIV protease inhibitors inhibit FACE1/ZMPSTE24: a mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy?
HIV-PIs (HIV protease inhibitors) have proved to be of great benefit for the millions of people suffering from AIDS. However, one of the side effects of this component of combined highly active antiretroviral therapy is lipodystrophy, which affects a large number of the patients taking this class of...
主要な著者: | Goulbourne, C, Vaux, D |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Portland Press
2010
|
類似資料
-
The structural basis of ZMPSTE24-dependent laminopathies
著者:: Quigley, A, 等
出版事項: (2013) -
The structural basis of ZMPSTE24-dependent laminopathies.
著者:: Quigley, A, 等
出版事項: (2013) -
Prelamin A and ZMPSTE24 in premature and physiological aging
著者:: Howard J. Worman, 等
出版事項: (2023-12-01) -
ZMPSTE24 Is Associated with Elevated Inflammation and Progerin mRNA
著者:: Moritz Messner, 等
出版事項: (2020-08-01) -
Requirements for efficient proteolytic cleavage of prelamin A by ZMPSTE24.
著者:: Jemima Barrowman, 等
出版事項: (2012-01-01)